Dactinomycin Market - Global Outlook and Forecast 2021-2027

April 2021 | 108 pages | ID: DAFC7B5F9ADDEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Dactinomycin in Global, including the following market information:

Global Dactinomycin Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Dactinomycin market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dactinomycin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dactinomycin Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Dactinomycin Market Segment Percentages, By Type, 2020 (%)

• Injection
• Implants

China Dactinomycin Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Dactinomycin Market Segment Percentages, By Application, 2020 (%)

• Alkylating Agent
• Hormone
• Plant Medicine

Global Dactinomycin Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Dactinomycin Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Dactinomycin Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Dactinomycin Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• AstraZeneca
• GSK
• Recordati Rare Diseases
• Lundbeck
• Merck
• Prasco Laboratories
• X-GEN Pharmaceuticals
• Mylan Institutional
• Bedford Pharmaceuticals
• HISUN
• Hainan Jinrui Pharmaceutical
• Qilu Pharmaceutical
• Shanghai Zhongke Pharmaceutical
• Shanghai Xinya Pharmaceutical
• Nantong Xinhe Biotechnology

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dactinomycin Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Dactinomycin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DACTINOMYCIN OVERALL MARKET SIZE

2.1 Global Dactinomycin Market Size: 2021 VS 2027
2.2 Global Dactinomycin Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Dactinomycin Players in Global Market
3.2 Top Global Dactinomycin Companies Ranked by Revenue
3.3 Global Dactinomycin Revenue by Companies
3.4 Top 3 and Top 5 Dactinomycin Companies in Global Market, by Revenue in 2020
3.5 Global Companies Dactinomycin Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dactinomycin Players in Global Market
  3.6.1 List of Global Tier 1 Dactinomycin Companies
  3.6.2 List of Global Tier 2 and Tier 3 Dactinomycin Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Dactinomycin Market Size Markets, 2021 & 2027
  4.1.2 Injection
  4.1.3 Implants
4.2 By Type - Global Dactinomycin Revenue & Forecasts
  4.2.1 By Type - Global Dactinomycin Revenue, 2016-2021
  4.2.2 By Type - Global Dactinomycin Revenue, 2022-2027
  4.2.3 By Type - Global Dactinomycin Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dactinomycin Market Size, 2021 & 2027
  5.1.2 Alkylating Agent
  5.1.3 Hormone
  5.1.4 Plant Medicine
5.2 By Application - Global Dactinomycin Revenue & Forecasts
  5.2.1 By Application - Global Dactinomycin Revenue, 2016-2021
  5.2.2 By Application - Global Dactinomycin Revenue, 2022-2027
  5.2.3 By Application - Global Dactinomycin Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Dactinomycin Market Size, 2021 & 2027
6.2 By Region - Global Dactinomycin Revenue & Forecasts
  6.2.1 By Region - Global Dactinomycin Revenue, 2016-2021
  6.2.2 By Region - Global Dactinomycin Revenue, 2022-2027
  6.2.3 By Region - Global Dactinomycin Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Dactinomycin Revenue, 2016-2027
  6.3.2 US Dactinomycin Market Size, 2016-2027
  6.3.3 Canada Dactinomycin Market Size, 2016-2027
  6.3.4 Mexico Dactinomycin Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Dactinomycin Revenue, 2016-2027
  6.4.2 Germany Dactinomycin Market Size, 2016-2027
  6.4.3 France Dactinomycin Market Size, 2016-2027
  6.4.4 U.K. Dactinomycin Market Size, 2016-2027
  6.4.5 Italy Dactinomycin Market Size, 2016-2027
  6.4.6 Russia Dactinomycin Market Size, 2016-2027
  6.4.7 Nordic Countries Dactinomycin Market Size, 2016-2027
  6.4.8 Benelux Dactinomycin Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Dactinomycin Revenue, 2016-2027
  6.5.2 China Dactinomycin Market Size, 2016-2027
  6.5.3 Japan Dactinomycin Market Size, 2016-2027
  6.5.4 South Korea Dactinomycin Market Size, 2016-2027
  6.5.5 Southeast Asia Dactinomycin Market Size, 2016-2027
  6.5.6 India Dactinomycin Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Dactinomycin Revenue, 2016-2027
  6.6.2 Brazil Dactinomycin Market Size, 2016-2027
  6.6.3 Argentina Dactinomycin Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Dactinomycin Revenue, 2016-2027
  6.7.2 Turkey Dactinomycin Market Size, 2016-2027
  6.7.3 Israel Dactinomycin Market Size, 2016-2027
  6.7.4 Saudi Arabia Dactinomycin Market Size, 2016-2027
  6.7.5 UAE Dactinomycin Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Dactinomycin Major Product Offerings
  7.1.4 AstraZeneca Dactinomycin Revenue in Global (2016-2021)
  7.1.5 AstraZeneca Key News
7.2 GSK
  7.2.1 GSK Corporate Summary
  7.2.2 GSK Business Overview
  7.2.3 GSK Dactinomycin Major Product Offerings
  7.2.4 GSK Dactinomycin Revenue in Global (2016-2021)
  7.2.5 GSK Key News
7.3 Recordati Rare Diseases
  7.3.1 Recordati Rare Diseases Corporate Summary
  7.3.2 Recordati Rare Diseases Business Overview
  7.3.3 Recordati Rare Diseases Dactinomycin Major Product Offerings
  7.3.4 Recordati Rare Diseases Dactinomycin Revenue in Global (2016-2021)
  7.3.5 Recordati Rare Diseases Key News
7.4 Lundbeck
  7.4.1 Lundbeck Corporate Summary
  7.4.2 Lundbeck Business Overview
  7.4.3 Lundbeck Dactinomycin Major Product Offerings
  7.4.4 Lundbeck Dactinomycin Revenue in Global (2016-2021)
  7.4.5 Lundbeck Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Dactinomycin Major Product Offerings
  7.5.4 Merck Dactinomycin Revenue in Global (2016-2021)
  7.5.5 Merck Key News
7.6 Prasco Laboratories
  7.6.1 Prasco Laboratories Corporate Summary
  7.6.2 Prasco Laboratories Business Overview
  7.6.3 Prasco Laboratories Dactinomycin Major Product Offerings
  7.6.4 Prasco Laboratories Dactinomycin Revenue in Global (2016-2021)
  7.6.5 Prasco Laboratories Key News
7.7 X-GEN Pharmaceuticals
  7.7.1 X-GEN Pharmaceuticals Corporate Summary
  7.7.2 X-GEN Pharmaceuticals Business Overview
  7.7.3 X-GEN Pharmaceuticals Dactinomycin Major Product Offerings
  7.4.4 X-GEN Pharmaceuticals Dactinomycin Revenue in Global (2016-2021)
  7.7.5 X-GEN Pharmaceuticals Key News
7.8 Mylan Institutional
  7.8.1 Mylan Institutional Corporate Summary
  7.8.2 Mylan Institutional Business Overview
  7.8.3 Mylan Institutional Dactinomycin Major Product Offerings
  7.8.4 Mylan Institutional Dactinomycin Revenue in Global (2016-2021)
  7.8.5 Mylan Institutional Key News
7.9 Bedford Pharmaceuticals
  7.9.1 Bedford Pharmaceuticals Corporate Summary
  7.9.2 Bedford Pharmaceuticals Business Overview
  7.9.3 Bedford Pharmaceuticals Dactinomycin Major Product Offerings
  7.9.4 Bedford Pharmaceuticals Dactinomycin Revenue in Global (2016-2021)
  7.9.5 Bedford Pharmaceuticals Key News
7.10 HISUN
  7.10.1 HISUN Corporate Summary
  7.10.2 HISUN Business Overview
  7.10.3 HISUN Dactinomycin Major Product Offerings
  7.10.4 HISUN Dactinomycin Revenue in Global (2016-2021)
  7.10.5 HISUN Key News
7.11 Hainan Jinrui Pharmaceutical
  7.11.1 Hainan Jinrui Pharmaceutical Corporate Summary
  7.11.2 Hainan Jinrui Pharmaceutical Business Overview
  7.11.3 Hainan Jinrui Pharmaceutical Dactinomycin Major Product Offerings
  7.11.4 Hainan Jinrui Pharmaceutical Dactinomycin Revenue in Global (2016-2021)
  7.11.5 Hainan Jinrui Pharmaceutical Key News
7.12 Qilu Pharmaceutical
  7.12.1 Qilu Pharmaceutical Corporate Summary
  7.12.2 Qilu Pharmaceutical Business Overview
  7.12.3 Qilu Pharmaceutical Dactinomycin Major Product Offerings
  7.12.4 Qilu Pharmaceutical Dactinomycin Revenue in Global (2016-2021)
  7.12.5 Qilu Pharmaceutical Key News
7.13 Shanghai Zhongke Pharmaceutical
  7.13.1 Shanghai Zhongke Pharmaceutical Corporate Summary
  7.13.2 Shanghai Zhongke Pharmaceutical Business Overview
  7.13.3 Shanghai Zhongke Pharmaceutical Dactinomycin Major Product Offerings
  7.13.4 Shanghai Zhongke Pharmaceutical Dactinomycin Revenue in Global (2016-2021)
  7.13.5 Shanghai Zhongke Pharmaceutical Key News
7.14 Shanghai Xinya Pharmaceutical
  7.14.1 Shanghai Xinya Pharmaceutical Corporate Summary
  7.14.2 Shanghai Xinya Pharmaceutical Business Overview
  7.14.3 Shanghai Xinya Pharmaceutical Dactinomycin Major Product Offerings
  7.14.4 Shanghai Xinya Pharmaceutical Dactinomycin Revenue in Global (2016-2021)
  7.14.5 Shanghai Xinya Pharmaceutical Key News
7.15 Nantong Xinhe Biotechnology
  7.15.1 Nantong Xinhe Biotechnology Corporate Summary
  7.15.2 Nantong Xinhe Biotechnology Business Overview
  7.15.3 Nantong Xinhe Biotechnology Dactinomycin Major Product Offerings
  7.15.4 Nantong Xinhe Biotechnology Dactinomycin Revenue in Global (2016-2021)
  7.15.5 Nantong Xinhe Biotechnology Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Dactinomycin Market Opportunities & Trends in Global Market
Table 2. Dactinomycin Market Drivers in Global Market
Table 3. Dactinomycin Market Restraints in Global Market
Table 4. Key Players of Dactinomycin in Global Market
Table 5. Top Dactinomycin Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Dactinomycin Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Dactinomycin Revenue Share by Companies, 2016-2021
Table 8. Global Companies Dactinomycin Product Type
Table 9. List of Global Tier 1 Dactinomycin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dactinomycin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Dactinomycin Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Dactinomycin Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Dactinomycin Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Dactinomycin Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Dactinomycin Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Dactinomycin Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Dactinomycin Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Dactinomycin Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Dactinomycin Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Dactinomycin Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Dactinomycin Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Dactinomycin Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Dactinomycin Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Dactinomycin Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Dactinomycin Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Dactinomycin Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Dactinomycin Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Dactinomycin Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Dactinomycin Revenue, (US$, Mn), 2022-2027
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Dactinomycin Product Offerings
Table 32. AstraZeneca Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 33. GSK Corporate Summary
Table 34. GSK Dactinomycin Product Offerings
Table 35. GSK Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 36. Recordati Rare Diseases Corporate Summary
Table 37. Recordati Rare Diseases Dactinomycin Product Offerings
Table 38. Recordati Rare Diseases Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 39. Lundbeck Corporate Summary
Table 40. Lundbeck Dactinomycin Product Offerings
Table 41. Lundbeck Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 42. Merck Corporate Summary
Table 43. Merck Dactinomycin Product Offerings
Table 44. Merck Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 45. Prasco Laboratories Corporate Summary
Table 46. Prasco Laboratories Dactinomycin Product Offerings
Table 47. Prasco Laboratories Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 48. X-GEN Pharmaceuticals Corporate Summary
Table 49. X-GEN Pharmaceuticals Dactinomycin Product Offerings
Table 50. X-GEN Pharmaceuticals Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 51. Mylan Institutional Corporate Summary
Table 52. Mylan Institutional Dactinomycin Product Offerings
Table 53. Mylan Institutional Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 54. Bedford Pharmaceuticals Corporate Summary
Table 55. Bedford Pharmaceuticals Dactinomycin Product Offerings
Table 56. Bedford Pharmaceuticals Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 57. HISUN Corporate Summary
Table 58. HISUN Dactinomycin Product Offerings
Table 59. HISUN Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 60. Hainan Jinrui Pharmaceutical Corporate Summary
Table 61. Hainan Jinrui Pharmaceutical Dactinomycin Product Offerings
Table 62. Hainan Jinrui Pharmaceutical Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 63. Qilu Pharmaceutical Corporate Summary
Table 64. Qilu Pharmaceutical Dactinomycin Product Offerings
Table 65. Qilu Pharmaceutical Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 66. Shanghai Zhongke Pharmaceutical Corporate Summary
Table 67. Shanghai Zhongke Pharmaceutical Dactinomycin Product Offerings
Table 68. Shanghai Zhongke Pharmaceutical Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 69. Shanghai Xinya Pharmaceutical Corporate Summary
Table 70. Shanghai Xinya Pharmaceutical Dactinomycin Product Offerings
Table 71. Shanghai Xinya Pharmaceutical Dactinomycin Revenue (US$, Mn), (2016-2021)
Table 72. Nantong Xinhe Biotechnology Corporate Summary
Table 73. Nantong Xinhe Biotechnology Dactinomycin Product Offerings
Table 74. Nantong Xinhe Biotechnology Dactinomycin Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Dactinomycin Segment by Type
Figure 2. Dactinomycin Segment by Application
Figure 3. Global Dactinomycin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Dactinomycin Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Dactinomycin Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dactinomycin Revenue in 2020
Figure 8. By Type - Global Dactinomycin Revenue Market Share, 2016-2027
Figure 9. By Application - Global Dactinomycin Revenue Market Share, 2016-2027
Figure 10. By Region - Global Dactinomycin Revenue Market Share, 2016-2027
Figure 11. By Country - North America Dactinomycin Revenue Market Share, 2016-2027
Figure 12. US Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Dactinomycin Revenue Market Share, 2016-2027
Figure 16. Germany Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 17. France Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Dactinomycin Revenue Market Share, 2016-2027
Figure 24. China Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 28. India Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Dactinomycin Revenue Market Share, 2016-2027
Figure 30. Brazil Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Dactinomycin Revenue Market Share, 2016-2027
Figure 33. Turkey Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Dactinomycin Revenue, (US$, Mn), 2016-2027
Figure 37. AstraZeneca Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. GSK Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Recordati Rare Diseases Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Lundbeck Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Merck Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Prasco Laboratories Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. X-GEN Pharmaceuticals Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Mylan Institutional Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Bedford Pharmaceuticals Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. HISUN Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Hainan Jinrui Pharmaceutical Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Qilu Pharmaceutical Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Shanghai Zhongke Pharmaceutical Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Shanghai Xinya Pharmaceutical Dactinomycin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)